knowledge -WSS

knowledge

author：hotspot 2025-10-02 13:14:15 - browse：3565

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Congress must reauthorize a committee to support older Americans

WSS

Morphosys mixed study results for blood cancer drug

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Diagnostic tests are hitting their mathematical limits

Diagnostic tests are hitting their mathematical limits

Rep. Raul Ruiz on the physician shortage and more

How to pay for weight loss drugs and save Medicare

leisure time

knowledge

hotspot

Peter Hotez and the public health issue of online harassment

CRISPR pioneers react to Casgevy, first gene

Novavax promises a turnaround & Lilly roils the obesity market

U.K. considers world's first use of meningitis vaccine to address gonorrhea

BioMarin wins approval for gene therapy to treat hemophilia A

Why medical students are struggling with mental health

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

How one medical school became remarkably diverse

In key trial, Verve's treatment lowers cholesterol levels in patients

knowledge

Why medical students are struggling with mental health

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Takeda, Janssen join wearable maker to measure scratching

Does good food count as health care? Study aims to find out

UnitedHealth’s Optum accused of antitrust violations in California

Hospitals look to new technology to keep health care workers safe

Wikipedia

leisure time

leisure time

Wikipedia